Off-Label Use Of Novo Drug May Harm Patients: Study
Novo Nordisk A/S' anti-bleeding drug for hemophiliacs has been increasingly used for off-label purposes such as hemorrhaging, though it is not effective and could increase the risk of blood clots, according...To view the full article, register now.
Already a subscriber? Click here to view full article